Recombinant human stem cell factor - Sinobiomed

Drug Profile

Recombinant human stem cell factor - Sinobiomed

Alternative Names: rh-SCF

Latest Information Update: 26 Jan 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sinobiomed
  • Class Antiasthmatics; Antineoplastics; Stem cell factors
  • Mechanism of Action Stem cell modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Haematological disorders

Most Recent Events

  • 08 Sep 2008 Phase-I clinical trials in Haematological disorders in China (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top